Pfizer (PFE) → Stock, financial statements

Pfizer: stocks, financial statements

Dividends News

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

  • PFE Ticker
  • 🇺🇸 NYSE, 🇩🇪 F, 🇩🇪 XETRA Exchange
  • 92,400 Employees
140 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements — Pfizer

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
42B 52B 54B 53B 53B
Cost Of Revenue
8.7B 10B 11B 11B 12B
Gross Profit
33B 42B 42B 41B 40B
Research and Development
9.4B 8.7B 8B 7.7B 7.9B
Selling General and Admin
12B 14B 14B 15B 15B
Operating Expense
33B 38B 39B 38B 39B
Operating Income
8.8B 14B 15B 14B 14B
Other Income Expense Net
1.1B 820M 980M 500M 910M
10B 15B 16B 15B 15B
Interest Income
1.4B 1.3B 980M 880M 720M
Pretax Income
7.5B 18B 12B 12B 8.4B
Income Tax
480M 1.4B 710M -9B 1.1B
Minority Interest
36M 29M 36M 47M 31M
Net Income
9.6B 16B 11B 21B 7.2B
Net Income Basic
9.6B 16B 11B 21B 7.2B
20 ← 16 2020 2019 2018 2017 2016
Current cash
12B 9.8B 19B 20B 18B
Short term investments
6.7B 5.9B 5.8B 5.3B 5.3B
7.9B 8.7B 8B 8.2B 8.2B
8B 8.3B 7.5B 7.6B 6.8B
Other current assets
6.7B 5.9B 5.8B 5.3B 5.3B
Current assets
35B 33B 50B 41B 39B
Long term investments
120B 130B 110B 130B 130B
Property plant equipment
14B 14B 13B 14B 13B
50B 59B 53B 56B 54B
Intangible assets
28B 35B 35B 49B 53B
Other assets
7B 6.5B 4.7B 5.1B 5.1B
Total assets
150B 170B 160B 170B 170B
Accounts payable
4.3B 4.2B 4.7B 4.7B 4.5B
Current long term debt
2.7B 16B 8.8B 10B 11B
Other current liabilities
19B 17B 18B 16B 16B
Total current liabilities
26B 37B 32B 30B 31B
Long term debt
37B 36B 33B 34B 31B
Other liabilities
24B 25B 27B 32B 19B
Minority Interest
240M 300M 350M 350M 300M
Total Liabilities
91B 100B 96B 100B 110B
Common stock
5.6B 5.6B 5.9B 6B 6.1B
Retained earning
97B 98B 90B 85B 72B
Treasury stock
-110B -110B -100B -89B -84B
Capital surplus
Shareholder equity
63B 63B 63B 71B 60B
Net tangible assets
-15B -31B -25B -33B -48B
20 ← 16 2020 2019 2018 2017 2016
Net Income
9.6B 16B 11B 21B 7.2B
4.8B 6B 6.4B 6.3B 5.8B
Changes in receivables
-790M 700M -200M -4M 49M
Changes in inventories
-240M 780M -71M 800M -730M
Cash change
2.4B -9B -1.2B 2.1B -5.4B
Cash flow
14B 13B 16B 16B 16B
Capital expenditures
-2.8B -2.6B -2B -2.2B -2B
Investing activity other
Total investing cash flows
-4.3B -3.9B 4.5B -4.7B -7.8B
Dividends paid
Net borrowings
21B 36B 17B 18B 19B
Other financing cash flows
Cash flow financing
-9.6B -8.5B -20B -13B -8.9B
Exchange rate effect